KANYOS BIO
Kanyos Bio was founded with the goal of developing antigen-specific immune tolerance technology for two specific autoimmune indications, type-1 diabetes and celiac disease. Our technology originated at EPFL (Ecole Polytechnique Fédérale Lausanne) in Switzerland with our sister company, Anokion. Kanyos and Anokion are collaborating in this effort with Astellas Pharma, Inc. (“Astellas”). As an independent affiliate, Kanyos aims to develop antigen-specific, disease-modifying therapies for patients with type-1 diabetes and celiac disease by leveraging the immunotechnology expertise of Anokion and the clinical translation experience of Astellas.
KANYOS BIO
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.kanyos.com
Total Employee:
1+
Status:
Active
Contact:
(312) 972-6001
Email Addresses:
[email protected]
Total Funding:
26.8 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail GoDaddy DNS GoDaddy ProfitBricks
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Venture Round - Kanyos Bio
Novo Ventures
Novo Ventures investment in Venture Round - Kanyos Bio
Official Site Inspections
http://www.kanyos.com
- Host name: 191.0.153.160.host.secureserver.net
- IP address: 160.153.0.191
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
